Y.D. More Investments Ltd Boosts Position in The Procter & Gamble Company (NYSE:PG)

Y.D. More Investments Ltd boosted its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 5.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,174 shares of the company’s stock after buying an additional 113 shares during the quarter. Y.D. More Investments Ltd’s holdings in Procter & Gamble were worth $318,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of PG. Wyrmwood Management LLC purchased a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $29,000. Naples Money Management LLC purchased a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $29,000. Criterion Capital Advisors LLC purchased a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $33,000. Mendota Financial Group LLC increased its holdings in shares of Procter & Gamble by 636.6% during the 4th quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after purchasing an additional 261 shares in the last quarter. Finally, DiNuzzo Private Wealth Inc. purchased a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $56,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Up 0.0 %

NYSE PG opened at $163.45 on Thursday. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $164.32. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The business’s fifty day simple moving average is $159.88 and its 200-day simple moving average is $153.97. The firm has a market cap of $385.76 billion, a PE ratio of 26.70, a P/E/G ratio of 3.31 and a beta of 0.43.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.37 EPS. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.46%. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s payout ratio is 65.85%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the company from $160.00 to $175.00 in a research note on Monday, March 11th. UBS Group lifted their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. JPMorgan Chase & Co. dropped their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. Finally, Wells Fargo & Company lifted their price target on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $169.76.

Insider Activity at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at $5,943,835.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now owns 4,859 shares in the company, valued at $768,256.49. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 86,865 shares of company stock worth $14,059,180. Company insiders own 0.17% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.